CONNECTING MOLECULES TO MEDICINE

Serial Number 90201288
Registration 6734284
700

Registration Progress

Application Filed
Sep 22, 2020
Under Examination
Approved for Publication
Mar 8, 2022
Published for Opposition
Mar 8, 2022
Registered
May 24, 2022

Trademark Image

CONNECTING MOLECULES TO MEDICINE

Basic Information

Serial Number
90201288
Registration Number
6734284
Filing Date
September 22, 2020
Registration Date
May 24, 2022
Published for Opposition
March 8, 2022
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
May 24, 2022
Registration
Registered
Classes
005

Rights Holder

NEXUS PHARMACEUTICALS II, LLC

16
Address
400 KNIGHTSBRIDGE PARKWAY
LINCOLNSHIRE, IL 60069

Ownership History

Nexus Pharmaceuticals, Inc.

Original Applicant
03
Lincolnshire, IL

Nexus Pharmaceuticals, Inc.

Owner at Publication
03
Lincolnshire, IL

Nexus Pharmaceuticals, Inc.

Original Registrant
03
Lincolnshire, IL

NEXUS PHARMACEUTICALS II, LLC

New Owner After Registration #1
16
LINCOLNSHIRE, IL

Legal Representation

Attorney
Randy Micheletti

Application History

23 events
Date Code Type Description Documents
Jul 5, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
May 25, 2022 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 24, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 16, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 29, 2022 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 27, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 27, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 25, 2022 ALIE A ASSIGNED TO LIE Loading...
Jan 20, 2022 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Loading...
Aug 16, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Aug 16, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Aug 16, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Aug 14, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 13, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 13, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 13, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 13, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 13, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 8, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 30, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 25, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of ocular disorders; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of metabolic disorders; Pharmaceutical preparations for the treatment of endocrine disorders; Pharmaceutical preparations for the treatment of cardiovascular diseases; Pharmaceutical preparations for the treatment of blood pressure disorders; Pharmaceutical preparations for the treatment of blood clotting disorders; Pharmaceutical preparations for the treatment of cancer-related conditions; Pharmaceutical preparations for the treatment of psychotic diagnoses; Pharmaceutical preparations for the treatment of gastrointestinal conditions
First Use Anywhere: Dec 2, 2018
First Use in Commerce: Dec 2, 2018

Classification

International Classes
005